CP
Chimanlal Purushottamdas Patel
About Chimanlal Purushottamdas Patel
Data last updated:
Chimanlal Purushottamdas Patel is a Director at German Remedies Pharmaceuticals Private Limited (since 2018), Director at Zydus Animal Health And Investments Limited (since 2018) and Director at Zydus Pharmaceuticals Limited (since 2019), and holds 4 more current directorships. The companies operate in Pharma and Machinery and Equipment. The 6 current companies with reported revenue have a combined latest revenue of ₹1,030 Cr; the largest is German Remedies Pharmaceuticals Private Limited at ₹547 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Mar 2018 | 2010 | ₹547 Cr (FY 2025) | Active | |
| Director | 06 Sep 2018 | 2018 | ₹334 Cr (FY 2025) | Active | |
| Director | 26 Dec 2019 | 2019 | ₹149 Cr (FY 2025) | Active | |
| Director | 12 Sep 2018 | 2005 | ₹31,000 (FY 2024) | Active | |
| Director | 20 Mar 2018 | 2018 | ₹26,300 (FY 2025) | Active | |
| Director | 12 Sep 2018 | 2005 | ₹25,000 (FY 2025) | Active | |
| Additional Director | 25 Aug 2025 | 2025 | Active |
Board colleagues of Chimanlal Purushottamdas Patel
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chimanlal Purushottamdas Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chimanlal Purushottamdas Patel
Chimanlal Purushottamdas Patel currently holds 7 directorships: German Remedies Pharmaceuticals Private Limited (Director, since 29 Mar 2018, revenue ₹547 Cr (FY 2025)); Zydus Animal Health And Investments Limited (Director, since 06 Sep 2018, revenue ₹334 Cr (FY 2025)); Zydus Pharmaceuticals Limited (Director, since 26 Dec 2019, revenue ₹149 Cr (FY 2025)); Dialforhealth Unity Limited (Director, since 12 Sep 2018, revenue ₹31,000 (FY 2024)); Violio Healthcare Limited (Director, since 20 Mar 2018, revenue ₹26,300 (FY 2025)); and 2 more.
Chimanlal Purushottamdas Patel was first appointed on 20 Mar 2018 as Director at Violio Healthcare Limited. The most recent appointment on record is 25 Aug 2025 at Sensotek Machinefabrik Industries Private Limited.
The 6 current companies of Chimanlal Purushottamdas Patel that report revenue have a combined latest revenue of ₹1,030 Cr: German Remedies Pharmaceuticals Private Limited ₹547 Cr (FY 2025); Zydus Animal Health And Investments Limited ₹334 Cr (FY 2025); Zydus Pharmaceuticals Limited ₹149 Cr (FY 2025); Dialforhealth Unity Limited ₹31,000 (FY 2024); Violio Healthcare Limited ₹26,300 (FY 2025); and 1 more.
The current boards of Chimanlal Purushottamdas Patel's companies include Arvind Bothra (German Remedies Pharmaceuticals Private Limited), Devanand Kumar Singh (German Remedies Pharmaceuticals Private Limited), Dharmishta Narendraprasad Raval (German Remedies Pharmaceuticals Private Limited), Jyotindra Bhogilal Gor (German Remedies Pharmaceuticals Private Limited), Rajib Baidya (German Remedies Pharmaceuticals Private Limited), Sanjay Kumar Gupta (German Remedies Pharmaceuticals Private Limited), among others.